Lines of therapy before autologous stem cell transplant and CAR-T affect outcomes in aggressive Non-Hodgkin's lymphoma

Am J Hematol. 2021 Oct 1;96(10):E386-E389. doi: 10.1002/ajh.26293. Epub 2021 Jul 29.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Immunotherapy, Adoptive
  • Lymphoma, Non-Hodgkin / therapy*
  • Middle Aged
  • Retrospective Studies
  • Stem Cell Transplantation
  • Transplantation, Autologous
  • Treatment Outcome